LUNG
Pulmonx Corp

398
Loading...
Loading...
News
all
press releases
What Makes Pulmonx (LUNG) a New Buy Stock
Pulmonx (LUNG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·12d ago
News Placeholder
More News
News Placeholder
After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG)
Pulmonx (LUNG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks·1mo ago
News Placeholder
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Pulmonx (LUNG) delivered earnings and revenue surprises of +5.00% and +1.25%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
Pulmonx Corporation (Nasdaq: LUNG) (Pulmonx), a global leader in minimally invasive treatments for severe lung disease, and the American Lung Association are continuing their ongoing collaboration...
Business Wire·10mo ago
News Placeholder
Navigating 6 Analyst Ratings For Pulmonx
Latest Ratings for LUNG DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsEqual-Weight Jan 2022Morgan StanleyMaintainsEqual-Weight View More Analyst...
Benzinga·1y ago
News Placeholder
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ( Pulmonx or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Globe Newswire·1y ago
News Placeholder
Short Interest in Pulmonx Co. (NASDAQ:LUNG) Decreases By 17.5%
Pulmonx Co. (NASDAQ:LUNG - Get Free Report) saw a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 17.5% from...
Ticker Report·1y ago
News Placeholder
Pulmonx Co. (NASDAQ:LUNG) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Pulmonx Co. (NASDAQ:LUNG Get Free Report) have been assigned a consensus recommendation of Moderate Buy from the six ratings firms that are currently covering the...
Ticker Report·1y ago
News Placeholder
Pulmonx (LUNG, $9.32) RSI Indicator left the oversold zone on March 19, 2024
This is a signal that LUNG's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks·1y ago
News Placeholder
Pulmonx (LUNG, $9.32) entered Uptrend as Momentum indicator ascends above 0 level on Mar 19, 2024
This indicator may be signaling LUNG's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks·1y ago

Latest LUNG News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.